🌍 Are you looking to connect with a global community shaping the future of drug repurposing? If so, iDR26 is the event for you! Join us 12&13 May in Brussels to explore how repurposing can help deliver treatments for patients worldwide. 🎟️ Learn more: https://loom.ly/ToR-dtw

💻📣 This week! Last chance to join the REMEDi4ALL webinar “IP Strategies for Repurposing” on Fri 21 Nov | 14:00–15:30 CET. Discover how IP strategies accelerate drug repurposing projects with LifeArc, King’s College London & Beacon for Rare Diseases. 🔗 https://loom.ly/bG6rhso

🔍 REMEDi4ALL at ISPOR Europe 2025 Partners from Syreon Research Institute represented REMEDi4ALL at #ISPOREurope2025 in Glasgow — sharing insights on policy barriers to drug repurposing and patient engagement in early HTA for Losartan in Osteogenesis Imperfecta. #DrugRepurposing #HTA

Why join #iDR26? Join a global community driving the future of drug repurposing. 💡 Cutting-edge science 🤝 Collaboration ⚖️ Policy & access 🔬 Real-world case studies Connect, share, and shape faster, more affordable treatments. 🔗 https://remedi4all.org/iDR26

📚REMEDi4ALL publishes a new systematic review in the British Journal of Pharmacology, identifying 33 key policy barriers limiting drug repurposing across Europe. Findings will guide future reforms to improve access to repurposed medicines. 📘More here: https://loom.ly/zCuz-oY

🏠First REMEDi4ALL Marketplace Meeting! The first REMEDi4ALL Marketplace meeting brought together 30+ participants, including 15 funding organisations. The Marketplace connects funders and project developers to boost impactful collaborations in drug repurposing. 🔗 https://loom.ly/YBi0wZU

📣 Medicines Reimagined Stories begins! Each month, we show how existing medicines find new life through #DrugRepurposing — turning known molecules into new treatments. 1st story: Sotatercept (Winrevair) — from anaemia to pulmonary hypertension (PAH). ➡️ Download here: https://loom.ly/4Qp4-yg

📣 Join us on 21 Nov for the REMEDi4ALL webinar on IP Strategies for Repurposing! With Beacon for Rare Diseases, LifeArc & King’s College London, discover how robust IP planning can accelerate your drug repurposing project. 🔗 https://loom.ly/bG6rhso

🎬 #iDR25 highlight reel is here! Relive the best moments from Amsterdam, where 300+ participants & 60+ experts came together to explore how AI, innovative trials & collaboration can transform #DrugRepurposing. ➡️ Watch the recap on the Conference hub: https://remedi4all.org/idr25-conference/

📅 It’s official! #iDR26 lands in Brussels on 12–13 May 2026. Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding. Early Bird tickets available now ➡️ https://remedi4all.org/iDR26

💻IP Strategies for Repurposing webinar 🗓️ 21 Nov | 14:00–15:30 CET Navigating the complex IP landscape in #DrugRepurposing? Join REMEDi4ALL with: ➡️ Madhu Madhusudhan & Svetlana Gracheva (LifeArc) ➡️ John Liddicoat (King’s College London) ➡️ Beacon for Rare Diseases 🔗: https://loom.ly/bG6rhso

🎤 #REMEDi4ALL takes the stage at the #iRDiRC General Assembly Meeting in Paris! Gathier Bouche from The Anticancer Fund joined a session on EU drug repurposing initiatives, where he showcased how REMEDi4ALL is advancing the repurposing of medicines. 🔗 https://irdirc.org/

💻New REMEDi4ALL Funders Network Webinar Barbara Goodman (Cures Within Reach) & Hans Platteeuw (Galenicap) shared seven #DrugRepurposing projects that reached patients plus key lessons learned. The Funders Network unites funders to boost collaboration & impact. 🔗More: https://loom.ly/ZTiu4mQ

At the 2025 #REMEDi4ALL Hackathon near Montserrat, 14 early career researchers from 10 countries joined experts to tackle real-world #DrugRepurposing challenges in rare neurodevelopmental disorders. Read the full event summary and discover who won here➡️https://loom.ly/N6tXCHs

👥 REMEDi4ALL #Hackathon2025: insights from our participants! As the Hackathon wraps up, participants share how speaking with patients shaped their approach to drug repurposing, showing how patient perspectives drive real-world impact. 🏆 Stay tuned - winner announced soon! 🔗 www.remedi4all.org

💻 Day 2 at the REMEDi4ALL Hackathon – the scientific programme! Participants are exploring and prioritising drug repurposing candidates for neurodevelopmental disorders, turning data into decisions and shaping target product profiles. Next: integrating patient perspectives for real-world impact!

💊Kicking off the REMEDi4ALL #Hackathon! 14 early-career researchers have joined us in Barcelona to explore repurposing candidates for three neurodevelopmental disorders. 📹 Stay tuned to hear directly from our participants and organisers as the week unfolds!

💻 Upcoming webinar: IP Strategies for Repurposing 🗓️ Fri 21 Nov | 14:00-15:30 CET Join REMEDi4ALL with Beacon for Rare Diseases, LifeArc & King’s College London to explore IP challenges, strategies & practical tips for drug repurposing. 🔗 Register here: https://loom.ly/bG6rhso

📄New publication from REMEDi4ALL. Researchers at FIMM have published in iScience on detecting spatial artefacts (systematic errors) in drug screening: key for advancing new and repurposed medicines. 🔗Our interview: https://loom.ly/UV5SWig 🔗Full publication: https://loom.ly/UV5SWig

👥 REMEDi4ALL joined our sister project REPO4EU at #RExPO25 in Barcelona for a programme on innovation in drug repurposing & systems medicine. Read highlights from our session: patient engagement, training, new tools & collaboration 👉 https://loom.ly/k4uER7w

🔬 New REMEDi4ALL dataset! Phospholipidosis, the abnormal build-up of lipids in cells, can distort drug screening results and slow development. REMEDi4ALL has shared imaging data to improve understanding of this phenomenon and support drug repurposing research. 🔗 https://loom.ly/sKA5Hp4

🌍 REMEDi4ALL is LIVE at #RExPO25 in Barcelona! Today we’re at Barcelona Biomedical Research Park for REPO4EU's annual conference, joining the community and taking the stage to discuss patient engagement, training, internationalisation and the REMEDi4ALL platform!

📣New opportunity with REMEDi4ALL! The REMEDi4ALL Partnering Portal is now open – creating a pathway for repurposing projects to collaborate with REMEDi4ALL. If you’re considering a proposal, we encourage you to first connect with the REMEDi4ALL Concierge. More➡️ https://loom.ly/xs12IxA

On 11–12 September, the REMEDi4ALL consortium gathered in Ljubljana for our fourth General Assembly Meeting. Over 50 members came together to reflect on progress, share achievements, and set priorities for the final two years of the project. Read more here➡️ https://loom.ly/jREI4bU

🎓New Digital Academy event! Join REMEDi4ALL’s Digital Academy with King’s College & LifeArc for a webinar on IP Strategies for Repurposing. Learn how to protect discoveries, tackle regulatory issues & move findings closer to patients. 🗓️ 21 Nov, 14:00–15:30 CET 🔗 https://loom.ly/dsFZvjU

🙌 Thank you to all who joined the #REMEDi4ALL General Assembly in Ljubljana. Our community’s dedication & expertise drive progress in #DrugRepurposing – working together to bring safe & effective drugs to more patients. ➡️ Updates: https://remedi4all.org/#REMEDi4ALL#DrugRepurposing #DrugRepurposing

🇸🇮 We’re live from Ljubljana for the #REMEDi4ALL General Assembly! After 3️⃣ years of collaboration, we’re looking back on our achievements & shaping the next steps to accelerate #PatientCentred medicines repurposing in Europe, & beyond. ➡️ More here: https://remedi4all.org #DrugRepurposing

📢Got a proposal for a #RareDisease #ClinicalTrial? Join our associated partner @lifearc.bsky.social Webinar & learn how experts can support you from protocol design & regulatory navigation to #PatientEngagement & #DataManagement. 🗓8 Oct 2025 ➡️Register: [email protected]

📣 REMEDi4ALL consortium partner Medicines for Europe, is looking for a Value Added Medicines Policy Manager with a passion for drug repurposing and interest in shaping policy to join their team in Brussels and lead their work within the REMEDi4ALL project! Apply here➡️ https://loom.ly/9ARRjuI

REMEDi4ALL and #iDR25 have been featured in Forbes, highlighting case studies in malaria, MND, CVS and RRP, the role of adaptive trial designs and patient input, and the need for stronger US–EU collaboration in drug repurposing. 📖 https://loom.ly/iY05I1A

Curious about drug repurposing and its impact? 🎥 Our latest video explains how repurposing existing medicines can accelerate access to effective treatments, benefitting patients and healthcare systems worldwide. Learn more 🌐➡️ www.remedi4all.org

📣 Funders of repurposing: planning a call for #DrugRepurposing research? Our Practical Guide gives you everything you need to get started, including real-world examples from the #REMEDi4ALL Funders Network. ➡️ Download: https://loom.ly/njyk7j0#DrugRepurposing#REMEDi4ALL#ResearchFunding

🔬 Looking to accelerate drug repurposing? Explore the REMEDi4ALL in-silico Drug Repurposing catalogue: an open resource helping researchers find new uses for existing drugs with advanced computational tools. Learn more: 📹 Guide: https://loom.ly/e0bBYjc 📄 Publication: https://loom.ly/F7KIRjM

Thanks to everyone who joined today’s webinar on AI-driven #DrugRepurposing clinical trials! Together with Beacon for Rare Diseases & Cures Within Reach, we explored how funding can turn predictions into patient benefit—especially in #RareDiseases. ➡️ More: https://loom.ly/5zgrVP4

🚨 New from REMEDi4ALL: a framework to assess the value of repurposed medicines! ✅ Tailored to unique needs of drug repurposing ✅ Supports early funding justification ✅ Validated across multiple stakeholders ✅ Free and open-access Explore here ⬇️ https://loom.ly/x6Y46o8

Join Beacon for Rare Diseases with Cures Within Reach & REMEDi4ALL on 31 July for a webinar exploring a new funding opportunity for AI-powered drug repurposing trials in rare diseases. 📅 31 July 🕞15:30 BST | 16:30 CEST 📝 Register: https://loom.ly/5zgrVP4 💡More info: https://loom.ly/QBMqtZY

💡At a recent REMEDi4ALL workshop, funders, observers and REMEDi4ALL consortium members explored our new framework for judging the project value of repurposed medicines. 📄Discover the resource here: https://loom.ly/x6Y46o8 👥Read about the workshop here: https://loom.ly/8LNkUGE

🧠 REMEDi4ALL joined Bionow’s 2025 Neuroscience Conference to discuss UK drug repurposing in neurological disorders! We spoke on the “State of the Nation” panel and reconnected with key players including UCL, Alzheimer’s UK & Serenatis Bio. More here ➡️ https://loom.ly/0N6y7IM

Want to revisit some of the #iDR25 Conference sessions? All resources are now available online for attendees, including: ✅delegate list ✅session recordings ✅ session slides ✅ posters presented ✅ articles, video highlights, photo gallery and more! 👉 https://loom.ly/_xSviOI

📢 REMEDi4ALL SOPs now on Zenodo! Explore our first 12 SOPs supporting best practices in drug repurposing, from in silico workflows to FAIR data & phospholipidosis assays. 🔗 https://loom.ly/TuB6ihg #DrugRepurposing #OpenScience #REMEDi4ALL

🔍 What’s new in the REMEDi4ALL Digital Academy? We’ve just added: 📄 New case studies to deepen your understanding of drug repurposing in action Want to explore our accessible digital learning platform? Swipe through to learn more ➡️ #REMEDi4ALL #DigitalAcademy #DrugRepurposing

👥 At the OIFE Annual Meeting 2025, REMEDi4ALL's Dalma Hosszú and Réka Pozsár (SRI) held a patient workshop to explore real-life challenges of living with OI. 🧠 Insights from 31 participants are now helping shape repurposing priorities. Thanks to OIFE for the warm welcome and collaboration!

💡 Funding now open for AI-driven drug repurposing projects! Cures Within Reach is seeking proposals for clinical trials to validate AI-driven drug repurposing. Open to global applicants in any disease area! 📅 Apply by 25 Aug 2025 👉 More info: https://loom.ly/QBMqtZY

📢 Applications for the REMEDi4ALL Hackathon are now closed! Thank you to everyone who applied! We are now reviewing your applications and look forward to bringing together an inspiring group in Barcelona this October. More REMEDi4ALL training➡️ loom.ly/thCPXrc

What is drug repurposing—and why does it matter? 💡 Discover how repurposing existing medicines can speed up access to treatments & benefit healthcare systems. Watch REMEDi4ALL’s explainer video & learn more: 🔗 www.youtube.com/watch?v=w69O... #DrugRepurposing #REMEDi4ALL

💻 Missed the REMEDi4ALL academic bootcamp? Catch up with new content now available in our Digital Academy! 📚 The Regulation module has fresh insights on regulatory frameworks + engaging with regulators. 🔗 loom.ly/3UeBnjA #RegulatoryScience #DigitalAcademy

🚨Why join the REMEDi4ALL Hackathon? Applications are now open for our hackathon on drug repurposing – here’s why you should join👇 💡Mentorship from top experts 🤝Real-world challenges 🌍European networking ⚡Lasting impact 📍Barcelona - 6–10 Oct 🔗 loom.ly/2V3NnfI

📣#iDR25 making headlines! El País spotlights drug repurposing advances — including how a hypertension pill may help children with epidermolysis bullosa. Great to see REMEDi4ALL and #iDR25 featured as key #DrugRepurposing initiatives! 🔗Read more: loom.ly/qzQoFDY

#iDR25 – That’s a wrap! 🌍 300+ joined us in Amsterdam for two days of panels, posters, and powerful discussions on smarter routes to repurposed medicines. 👥 Thanks to our speakers and attendees for your insights, energy & contributions. 📖Highlights: remedi4all.org/idr25-wraps-...

Day 2 of #iDR25 is in full swing! We're tackling #DrugRepurposing, AI, #ClinicalTrial innovation, #PatientSccess, & more. 📸 Daria Julkowska, @erdera.bsky.social: “ #ERDERA aims to deliver real health gains for #RareDisease patients in the next decade.” #DrugRepurposing